Features

Features

Podcast: The impact of prediction markets on the clinical sector

Publicly traded drug developers have been exposed to insider trading on their stocks for decades, but with the introduction of…

Frankie Fattorini

Features

Women’s health landscape shifting, but systemic hurdles remain

Features

Podcast: Key takeaways from EASD 2026 on where GLP-1s are headed

PremiumFeatures

GLP-1RA non-responders: tackling a hidden challenge behind the obesity epidemic

Features

Magazine: Keep it cool

Features

Podcast: How Sandoz plans to harness its “golden decade”

PremiumFeatures

The shrinking return on investment for Nordic innovation

PremiumFeatures

Staunch biotech competition spurs new secretive tactics, shifts investor approach

Features

Podcast: key readouts from ESC and ERS

PremiumFeatures

Osaka has the science. Now it needs the business

Catherine Longworth

Features

Peptide innovator says the drug class is due for a rethink

Frankie Fattorini

PremiumFeatures

MSD’s Lipfendra takes on injectable rivals for cholesterol-lowering market supremacy

PremiumFeatures

MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones

Frankie Fattorini

PremiumFeatures

A strategic shift for gene therapies: manufacturing and market size take centre stage

PremiumFeatures

Health tech’s role in obesity to expand beyond a ‘nice-to-have’

Annabel Kartal Allen

PremiumFeatures

Orexin receptor agonists set to propel narcolepsy treatment into a new era

Features

Boosting CGT access: a global consideration with wide-spanning benefits

Annabel Kartal Allen

Features

Magazine: Made in the USA

Features

AAIC26: Alzheimer’s disease heterogeneity calls for a rethink

Annabel Kartal Allen

Features

Podcast: Patient advocates join the blood cancer ASCT vs CAR-T debate

Annabel Kartal Allen

Features

Podcast: Servier describes its M&A and manufacturing strategy amidst deal-making drive

Frankie Fattorini

Features

Between two giants: Europe’s new oncology chapter takes shape in Paris

Catherine Longworth

Features

The celebrity prescription: star power meets healthcare

Features

Podcast: HLTH Europe and BIO key trends rundown

Annabel Kartal Allen , Robert Barrie and Frankie Fattorini

Features

Beyond the GLP-1RA weight loss ceiling

Frankie Fattorini

Features

HLTH Europe 2026: Healthcare implementation key amid European innovation rush

Annabel Kartal Allen

Features

ASCO26: RLTs bring the buzz, but commercial and tolerability qualms remain

Annabel Kartal Allen

Features

How biotech executives are confronting funding and regulatory shifts

Features

Can AI predict the (regulatory) future?

Frankie Fattorini

Interviews

Coya Therapeutics CEO on ALS urgency and fast-tracking COYA 302 for patient impact

Salong Debbarma

Features

Dangerous waters: Geopolitics, supply chains and access to medicines

Features

Novo Nordisk puts AI at the centre of its clinical strategy

Frankie Fattorini

Features

Shift in biosimilar commercial landscape essential for sector sustainability, expert says

Annabel Kartal Allen

Features

ASCO26 Podcast: an analyst rundown of the best readouts and key trends

Annabel Kartal Allen

Features

Psychedelic-assisted therapies get a boost, but systems struggle to play catch-up

Features

Validation to velocity: Japan’s pharma model comes under execution pressure

Catherine Longworth

Features

Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trends

Features

AI-guided labs are approaching full autonomy

Frankie Fattorini

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close